Advances in cardiac implantable electronic device infection prevention: should we push the envelope?

Cardiac implantable electronic devices (CIEDs) including pacemakers, implantable cardioverter defibrillators and loop recorders have become widespread adjuncts in the care of patients with cardiovascular disease. CIEDs provide increased diagnostic yield, better quality of life and improved longevity...

Full description

Saved in:
Bibliographic Details
Published in:Future cardiology 2018-09, Vol.14 (5), p.359-366
Main Authors: Lambert, Cameron T, Wilkoff, Bruce L, Tarakji, Khaldoun G
Format: Article
Language:English
Subjects:
Alcohol
Antibiotics
CIED
Defibrillators
infection
Infections
Mortality
Patients
Prevention
Studies
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiac implantable electronic devices (CIEDs) including pacemakers, implantable cardioverter defibrillators and loop recorders have become widespread adjuncts in the care of patients with cardiovascular disease. CIEDs provide increased diagnostic yield, better quality of life and improved longevity. While there are obvious benefits with these devices, the mere fact that these therapies involve implantation of a foreign device within the body leads to certain risks. The most feared complication associated with CIED use is infection. While the incidence of CIED infection is relatively low for first-time implants, the consequences are serious and involve increased morbidity and mortality despite optimal management. In this review, we discuss preventive practices including a new antimicrobial envelope aimed at reducing the risk of CIED infections.
ISSN:1479-6678
1744-8298
DOI:10.2217/fca-2018-0039